COMMUNIQUÉS West-GlobeNewswire

Precipio To Announce Third Quarter 2017 Financial Results and Provide a Company Update on Monday, November 20, 2017 at 4:05pm Eastern Time
16/11/2017
NEW HAVEN, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), today announced it will issue financial results for the Third Quarter ended September 30, 2017 and provide an update on corporate [...]
Vericel to Present at 29th Annual Piper Jaffray Healthcare Conference
16/11/2017
CAMBRIDGE, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, [...]
Neuralstem Announces Presentation of Clinical Data for NSI-189 in Major Depressive Disorder at the Upcoming American College of Neuropsychopharmacology Annual Meeting
16/11/2017
GERMANTOWN, Md., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that data from the Company’s Phase [...]
Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights
16/11/2017
MENLO PARK, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]
Ascendis Pharma A/S Reports Third Quarter 2017 Financial Results
16/11/2017
- Phase 3 Program for TransCon Growth Hormone Advances and TransCon PTH Enters the Clinic - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S [...]
VBL Therapeutics Announces Proposed Public Offering of 2.5 Million Shares of Ordinary Shares
16/11/2017
TEL AVIV, Israel, Nov. 16, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Asterias Biotherapeutics to Present at Piper Jaffray Healthcare Conference on November 28, 2017
16/11/2017
FREMONT, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Michael Mulroy, President and [...]
Biodesix Announces New Data Demonstrating Analytic Validity of Automated RNA Extraction from Plasma with the GeneStrat® Test
16/11/2017
BOULDER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Biodesix ® announced data demonstrating that a novel, automated method for extracting circulating RNA from plasma performed equivalently or better than the established [...]
Arbutus’ LNP Licensee Alnylam Initiates Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration (FDA) for Patisiran
16/11/2017
VANCOUVER, B.C. and WARMINSTER, Pa., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, announced today that the [...]
Thetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease
16/11/2017
BRANFORD, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals, a biopharmaceutical company developing “immuno-resolving” therapies for treatment of inflammatory bowel disease (IBD), today announced the [...]
Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
16/11/2017
TUCSON, Ariz., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Charles Watts, M.D. to the company’s board of directors. His appointment is effective November 14, 2017. Dr. [...]
Konica Minolta’s AeroRemote Insights Provides Interactive Analytic Reporting for Radiology Departments
16/11/2017
WAYNE, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a recognized leader in medical imaging systems and healthcare IT, unveils AeroRemote™ Insights, a new web-based tool designed to [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2017
16/11/2017
Communiqué de presse Villepinte, le 16 novembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sectional Annual Meeting in Scottsdale
16/11/2017
HASBROUCK HEIGHTS, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the Annual Meeting of [...]
The Chartis Center for Rural Health Celebrates National Rural Health Day with 2017 Performance Leadership Awards
16/11/2017
Portland, ME, Nov. 16, 2017 (GLOBE NEWSWIRE) -- In celebration of National Rural Health Day, The Chartis Center for Rural Health and iVantage Health Analytics today announced the recipients of the 2017 National [...]
Insider tradings
16/11/2017
Please see enclosed pdf.
New data shows more needs to be done to keep kids with diabetes safe at school
16/11/2017
OTTAWA, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nearly one-third of Ontario parents aren’t confident that school staff can keep their kids with type 1 diabetes safe, according to new data released today by the Canadian [...]
Premier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-President
16/11/2017
El Paso, Texas, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: " BIEI ") announced the appointment of retired NFL Pro Football Hall of Famer, Carl Eller, to the post of Marketing and Planning Vice- [...]
Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer
16/11/2017
Newark, NJ, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical [...]

Pages